If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,446.00    -2.00 (-0.14%)
Bid:
1,446.00
Ask:
1,454.00
Spread: 8.00 (0.553%)
Market Cap: £495.07m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

esMD Certification

29 Aug 2012 07:00

RNS Number : 9447K
Craneware plc
29 August 2012
 

29 August 2012 - RNS Reach

 

Craneware plc

("Craneware" or the "Company")

 

Craneware Certified by US Federal Agency to provide mechanism for electronic submission of medical documentation

 

Craneware plc (AIM: CRW.L), the market leader in automated revenue integrity solutions for the US healthcare market, today announced that it has achieved Electronic Submission of Medical Documentation (esMD) certification from the Centers for Medicare and Medicaid Services (CMS). With this certification, Craneware is now authorised to offer esMD gateway services to healthcare organisations to enable the electronic submission of medical records to auditors.

 

As one of only a small number of esMD-certified Health Information Handlers (HIH), Craneware's InSight Audit™ solution will enable the digital submission of medical record documentation, facilitating the adoption of streamlined processes amidst increasing healthcare audits. This capability will increase efficiency of the audit process and assist hospitals and health networks with the collection and retention of earned revenue to improve the efficiency of audit defense, including Medicare Recovery Audits (formerly RAC) and Medicare Administrative Contractor (MAC) audits. In phase two of the esMD program, which will begin in 2013, review contractors will also be able to electronically send Additional Documentation Requests (ADR) to providers via approved HIH vendors.

 

Keith Neilson, CEO of Craneware commented, "CMS' esMD program increases the efficiencies around documentation requests to ensure improper payments are handled as quickly as possible. Since the early days of the RAC demonstration project, Craneware's InSight Audit knowledgebase has grown and now, in becoming an esMD-certified vendor, we have expanded the capabilities of our Audit and Revenue Recovery solutions to support our clients' document submission needs with CMS. As a certified esMD provider, we help clients efficiently comply with documentation requests and support CMS in its goal to transform electronic communications via these gateways, particularly as esMD promises to become the future of audit tracking."

 

 

For further information, please contact:

 

Craneware plc

Peel Hunt

Newgate Threadneedle

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)20 7653 9850

Keith Neilson, CEO

Dan Webster

Caroline Evans-Jones

Craig Preston, CFO

Richard Kauffer

Fiona Conroy

Heather Armstrong

 

 

About Craneware

 

Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Arizona, Massachusetts and Tennessee employing over 220 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance for healthcare organisations. Craneware's market-driven, SaaS solutions help hospitals and other healthcare providers more effectively price, charge, code and retain earned revenue for patient care services and supplies. This optimises reimbursement, increases operational efficiency and minimises compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com and stoptheleakage.com 

 

Craneware's InSight Audit is a fully hosted, Web-based solution that provides healthcare organizations with one central location for managing all medical claims audits. The solution offers a full set of features for submitting, tracking and appealing claims in response to a range of audits, including Medicare Recovery Audits, MAC audits, and commercial payor audits. Craneware's InSight Audit Knowledgebase contains the latest information on best practices and payment rules, providing valuable audit-specific content that includes templates, checklists, and request forms.

 

Craneware Revenue Integrity Solutions® span four product families: Audit & Revenue Recovery, Revenue Cycle, Supply Management, and Access Management & Strategic Pricing. Craneware developed the industry's first chargemaster management solution, Craneware's Chargemaster Toolkit® has ranked number one in the KLAS Revenue Cycle - Chargemaster Management market category for the past six years. In 2011 Craneware's Bill Analyzer achieved number one ranking in the KLAS Revenue Cycle - Other market category.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUWUARURAWUUR
Date   Source Headline
29th Sep 20237:00 amRNSTransaction in Own Shares
28th Sep 20237:00 amRNSTransaction in Own Shares
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
7th Sep 20234:41 pmRNSExercise of Share Options
7th Sep 202310:04 amRNSGrant of Long Term Incentive Plan Awards
5th Sep 20237:00 amRNSFinal Results
1st Sep 20237:00 amRNSTransaction in Own Shares
31st Aug 20237:00 amRNSTransaction in Own Shares
30th Aug 20237:00 amRNSTransaction in Own Shares
29th Aug 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in Own Shares
23rd Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 20237:00 amRNSTransaction in Own Shares
17th Aug 20237:00 amRNSTransaction in Own Shares
16th Aug 20237:00 amRNSTransaction in Own Shares
15th Aug 20237:00 amRNSTransaction in Own Shares
8th Aug 20237:00 amRNSTransaction in Own Shares
7th Aug 20237:00 amRNSTransaction in Own Shares
2nd Aug 20237:00 amRNSTransaction in Own Shares
27th Jul 20237:00 amRNSTransaction in Own Shares
24th Jul 20237:00 amRNSTransaction in Own Shares
21st Jul 20237:00 amRNSTransaction in Own Shares
19th Jul 20237:00 amRNSTransaction in Own Shares
17th Jul 20237:00 amRNSFY23 Trading Update and Notice of Results
13th Jul 20237:00 amRNSTransaction in Own Shares
12th Jul 20237:00 amRNSTransaction in Own Shares
11th Jul 20237:00 amRNSTransaction in Own Shares
10th Jul 20237:00 amRNSTransaction in Own Shares
7th Jul 20237:00 amRNSTransaction in Own Shares
6th Jul 20237:00 amRNSTransaction in Own Shares
5th Jul 20237:00 amRNSTransaction in Own Shares
3rd Jul 20237:00 amRNSTransaction in Own Shares
30th Jun 20237:00 amRNSTransaction in Own Shares
29th Jun 20237:00 amRNSTransaction in Own Shares
27th Jun 20237:00 amRNSTransaction in Own Shares
26th Jun 20237:00 amRNSTransaction in Own Shares
23rd Jun 20237:00 amRNSTransaction in Own Shares
22nd Jun 20237:00 amRNSTransaction in Own Shares
21st Jun 20237:00 amRNSTransaction in Own Shares
20th Jun 20237:00 amRNSTransaction in Own Shares
19th Jun 20234:44 pmRNSHolding(s) in Company
19th Jun 20237:00 amRNSTransaction in Own Shares
16th Jun 20237:00 amRNSTransaction in Own Shares
15th Jun 20237:00 amRNSTransaction in Own Shares
14th Jun 20237:00 amRNSTransaction in Own Shares
13th Jun 20237:00 amRNSTransaction in Own Shares
12th Jun 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.